Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Systematische Dokumentation Von Patienten Mit Akutem HIT-Verdacht

NCT01304238 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT01304238
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01304238 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Systematische Dokumentation Von Patienten Mit Akutem HIT-Verdacht
Lead sponsor
GlaxoSmithKline
Phase
Observational
Overall status
Completed
Start date
February 28, 2009
Completion date
January 31, 2010
Enrollment
195 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

acute hit ii (heparin-induced thrombocytopenia type ii)